" /> Bevacizumab/Irinotecan Regimen - CISMeF





Preferred Label : Bevacizumab/Irinotecan Regimen;

NCIt synonyms : Irinotecan/Bevacizumab; Irinotecan-Bevacizumab; Irinotecan-Bevacizumab Regimen; Irinotecan/Avastin Regimen; Irinotecan-Avastin Regimen; Irinotecan/Bevacizumab Regimen;

NCIt related terms : Irinotecan and Bevacizumab; Irinotecan and Bevacizumab-maly; Irinotecan and Bevacizumab-onbe; Irinotecan and Bevacizumab-adcd; Irinotecan and Bevacizumab-bvzr; Irinotecan and Bevacizumab-equi; Irinotecan and Bevacizumab-awwb; Irinotecan and Bevacizumab-aybi; Irinotecan and Bevacizumab-tnjn;

NCIt definition : A regimen consisting of irinotecan and bevacizumab that can be used for the treatment of colorectal cancer and appendiceal adenocarcinoma.;

NCI Metathesaurus CUI : CL523569;

Codes from synonyms : 3393; 127587; 127143; 127365; 127513; 127217; 127439; 127291; 143809;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.